check_boxCHECK ALL check_box_outline_blankUNCHECK ALL

Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999–2015.

Lim MC , Won YJ , Ko MJ , Kim M , Shim SH , Suh DH , Kim JW .

J Gynecol Oncol. 2019 Jan;30(1):e38. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e38

Opportunistic salpingectomy in the Netherlands.

Tamussino K .

J Gynecol Oncol. 2019 Jan;30(1):e33. English. Editorial. https://doi.org/10.3802/jgo.2019.30.e33

Tailoring radicality in early cervical cancer: how far can we go?

van der Velden J , Mom CH .

J Gynecol Oncol. 2019 Jan;30(1):e30. English. Randomized Controlled Trial. https://doi.org/10.3802/jgo.2019.30.e30

Peritoneal cancer index in ovarian cancer.

Shin W , Park SY , Lim MC .

J Gynecol Oncol. 2019 Jan;30(1):e14. English. Letter. https://doi.org/10.3802/jgo.2019.30.e14

The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.

Guan J , Xie L , Luo X , Yang B , Zhang H , Zhu Q , Chen X .

J Gynecol Oncol. 2019 Jan;30(1):e13. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e13

Serum calcium is a novel parameter to assess metabolic syndrome in endometrial carcinoma.

Lin Y , Zhou J , Cao L , Xu Q , Hao J , Zhao L , Wang J .

J Gynecol Oncol. 2019 Jan;30(1):e12. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e12

Optimal cutoff age for predicting prognosis associated with serous epithelial ovarian cancer: what is the best age cutoff?

Kim J , Chang Y , Kim TJ , Lee JW , Kim BG , Bae DS , Choi CH .

J Gynecol Oncol. 2019 Jan;30(1):e11. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e11

Current state and outlook for drug repositioning anticipated in the field of ovarian cancer.

Kobayashi Y , Banno K , Kunitomi H , Tominaga E , Aoki D .

J Gynecol Oncol. 2019 Jan;30(1):e10. English. Review. https://doi.org/10.3802/jgo.2019.30.e10

Efficacy and dosimetry analysis of image-guided radioactive ¹²⁵I seed implantation as salvage treatment for pelvic recurrent cervical cancer after external beam radiotherapy.

Qu A , Jiang P , Sun H , Jiang W , Jiang Y , Tian S , Wang J .

J Gynecol Oncol. 2019 Jan;30(1):e9. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e9

A novel prediction score for predicting the baseline risk of recurrence of stage I–II endometrial carcinoma.

Takahashi K , Yunokawa M , Sasada S , Takehara Y , Miyasaka N , Kato T , Tamura K .

J Gynecol Oncol. 2019 Jan;30(1):e8. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e8

Prognostic factors of synchronous endometrial and ovarian endometrioid carcinoma.

Yoneoka Y , Yoshida H , Ishikawa M , Shimizu H , Uehara T , Murakami T , Kato T .

J Gynecol Oncol. 2019 Jan;30(1):e7. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e7

The age-adjusted Charlson comorbidity index as a predictor of survival in surgically treated vulvar cancer patients.

Di Donato V , Page Z , Bracchi C , Tomao F , Musella A , Perniola G , Panici PB .

J Gynecol Oncol. 2019 Jan;30(1):e6. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e6

Association of pretreatment thrombocytosis with prognosis in ovarian cancer: a systematic review and meta-analysis.

Ye Q , Cheng J , Ye M , Liu D , Zhang Y .

J Gynecol Oncol. 2019 Jan;30(1):e5. English. Meta-Analysis. https://doi.org/10.3802/jgo.2019.30.e5

The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer.

Bogani G , Leone Roberti Maggiore U , Paolini B , Diito A , Martinelli F , Lorusso D , Raspagliesi F .

J Gynecol Oncol. 2019 Jan;30(1):e4. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e4

Incorporation of paclitaxel-based hyperthermic intraperitoneal chemotherapy in patients with advanced-stage ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery: a protocol-based pilot study.

Lee YJ , Lee JY , Cho MS , Nam EJ , Kim SW , Kim S , Kim YT .

J Gynecol Oncol. 2019 Jan;30(1):e3. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e3

Factors influencing decision-making around opportunistic salpingectomy: a nationwide survey.

Steenbeek MP , van Lieshout LA , Aarts JW , Piek JM , Coppus SF , Massuger LF , Hermens RP , de Hullu JA .

J Gynecol Oncol. 2019 Jan;30(1):e2. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e2

Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.

Choi KH , Lee SW , Yu M , Jeong S , Lee JW , Lee JH .

J Gynecol Oncol. 2019 Jan;30(1):e1. English. Original Article. https://doi.org/10.3802/jgo.2019.30.e1